Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy

Kidney International

Volumn 57, Issue 3, 2000, Pages 1002-1014

  Wang, Shi Nong ^a   Lapage, Janine ^a   Hirschberg, Raimund ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Diabetic nephropathy; Fibronectin; Growth factor; Hepatocyte; MCP 1; Proteinuria; TGF

Indexed keywords

SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION; KIDNEY FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; ULTRAFILTRATION;

EID: 0033917987     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00928.x     Document Type: Conference Paper

References (42)

1. PETERSON JC, ADLER S, BURKART JM, GREENE T, HEBERT LA, HUNSICKER LG, KING AJ, KLAIIR S, MASSRY SG, SHIFTER JL: Blood pressure control, proteinuria, and the progression of renal disease. The Modification Diet Renal Disease Study. Ann Intern Med 123:754-762, 1995
2. JERUMS G, PANAGIOTOPOULOS S, TSALAMANDRIS C, ALLEN T, GILBERT R, COMPER W: Why is proteinuria such an important risk factor for progression in clinical trials? Kidney Int 52(Suppl 63):S87-S92, 1997
3. RUGGENENTI P, PERNA A, MOSCONI L, MATALONE M, PlSONI R, GASPARI F, REMUZZI G: Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. Kidney Int 52(SuppI 63): S54-S57, 1997
4. BOHLE A: Importance of the renal interstitium for kidney function. Klin Wochensclir 60:1186-1190, 1982
5. STRUTZ F, NEILSON EG: The role of lymphocytes in the progression of interstitial disease. Kidney Int 45(Suppl 45):S106-S110, 1994
6. BOHLE A, WEIIRMANN M, BOGENSCIIUTZ O, BATZ C, MULLER CA, MULLER GA: The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract 187:251-259, 1991
7. BOHLE A, WEIIRMANN M, MACKENSEN-HAEN S, GISE H, MICKELER E, XIAO TC, MULLER C, MULLER GA: Pathogenesis of chronic renal failure in primary glomerulopathies. Nephrol Dial Transplant 9(Suppl 3):4-12, 1994
8. EDDY AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions, [editorial] J Am Soc Nephrol 5:1273-1287, 1994
9. REMUZZI G, RUGGENENTI P, BENIGNI A: Understanding the nature of renal disease progression. Kidney Int 51:2-15, 1997
10. HOTTA O, KITAMURA H, TAGUMA Y: Detection of mature macrophages in urinary sediments: Clinical significance in predicting progressive renal disease. Renal Fail 20:413-418, 1998
11. FURNESS PN, RooERS-WiiEATLEY L, HARRIS KP: Semiautomatic quantitation of macrophages in human renal biopsy specimens in proteinuric states. J Clin Patlwl 50:118-122, 1997
12. HIRSCHBERG R: Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: Evidence for a role for insulin-like growth factor I. J Clin Invest 98:116-124, 1996
13. WANG S, LAPAGE J, HIRSCHBERG R: Glomerular ultrafiltration of IGF-I may contribute to increased renal sodium retention in diabetic nephropathy. J Lab Clin Med 134:154-160, 1999
14. WANG S, LAPAGE J, HIRSCHBERG R: Glomerular ultrafiltration and apical tubular action of IGF-I, TGF-beta and HGF in the nephrotic syndrome. Kidney Int 56:1247-1251, 1999
15. ANDO T, OKUDA S, YANAGIDA T, FUJISIIIMA M: Localization of TGF-beta and its receptors in the kidney. Miner Electrolyte Metab 24:149-153, 1998
16. MIZUNO K, TAKEHARA T, NAKAMURA T: Proteolytic activation of a single-chain precursor of hepatocyte growth factor by extracellular serine-protease. Biochem Biophys Res Commun 189:1631-1638, 1992
17. ROBERTS A: Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24:111-119,1998
18. HIRSCHBERG R, KOPPLE JD, BLANTZ RC, TUCKER BJ: Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J Clin Invest 87:1200-1206, 1991
19. HIRSCHBERG R, KAYSEN GA: Insulin-like growth factor I and its binding proteins in the experimental nephrotic syndrome. Endocrinology 136:1565-1571, 1995
20. ABE M, HARPEL JG, METZ CN, NUNES I, LOSKUTOFF DJ, RIFKIN DB: An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 216:276-284, 1994
21. HAVERTY TP, KELLY CI, HINES WH, AMENTA PS, WATANABE M, HARPER RA, KEFALIDES NA, NEILSON EG: Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J Cell Biol 107:1359-1368, 1988
22. NALDINI L, TAMAGNONE L, VIGNA E, SACHS M, HARTMANN G, BiRCHMEiER W, DAIKUHARA Y, TSUBOUCHI H, BLASI F, COMOGLIO PM: Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO 711:4825-4833, 1992
23. WAGNER SN, ATKINSON MJ, WAGNER C, HOFLER H, SCIIMITT M, WILHELM O: Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney. Hislochem Cell Biol 105:53-60, 1996
24. Kuo BS, BJORNSSON TD: Simultaneous determination of free tissue-type and free urokinase-type plasminogen activators in biological fluids by a solid-phase immunoassay. Anal Biochem 209:70-78, 1993
25. MUNGER JS, HARPEL JG, GLEIZES PE, MAZZIERI R, NUNES I, RIFKIN DB: Latent transforming growth factor-beta: Structural features and mechanisms of activation. Kidney Int 51:1376-1382, 1997
26. CRAWFORD S, STELLMACH V, MURPHY-ULLRICH J, RIBEIRO S, LAWLER J, HYNES R, BOIVIN G, BOUCK N: Thrombospondin-1 is a major activator of TGF-betal in vivo. Cell 93:1159-1170, 1998
27. Cui S, FLYVBJERG A, NIELSEN S, KIESS W, CIIRISTENSEN EI: IGF-II/Man-6-P receptors in rat kidney: Apical localization in proximal tubule cells. Kidney Int 43:796-807, 1993
28. FLYVBJERG A, NIELSEN S, SHEIKH MI, JACOBSEN C, ORSKOV H, CHRISTENSEN El: Luminal and basolateral uptake and receptor binding of IGF-I in rabbit renal proximal tubules. Am J Physiol 265:F624-F633, 1993
29. QUIGLEY R, BAUM M: Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport. J Clin Invest 88:368-374, 1991
30. SATO H, IWANO M, AKAI Y, KURIOKA H, KUBO A, YAMAGUCHI T, HIRATA E, KANAUCHI M, Dom K: Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy. Am J Nephrol 18:490-494, 1998
31. HONKANEN E, TEPPO AM, TORNROTH T, GROOP PH, GRONHAGENRISKA C: Urinary transforming growth factor-beta 1 in membranous glomerulonephritis. Nephrol Dial Transplant 12:2562-2568, 1997
32. WANG Y, CHEN J, CHEN L, TAY YC, RANGAN GK, HARRIS DC: Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 8:1537-1545,1997
33. ROVTN BH, DOE N, TAN LC: Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am J Kidney Dis 27:640-646, 1996
34. BERTANI T, CUTILLO F, ZOJA C, BROGGINI M, REMUZZI G: Tubulointerstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int 30:488-496, 1986
35. SCHILLER B, MORAN J: Focal glomerulosclerosis in the remnant kidney model - an inflammatory disease mediated by cytokines. Nephrol Dial Transplant 12:430-437, 1997
36. RANDOLPH GJ, FURIE MB: A soluble gradient of endogenous mono-cyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro. J Iinmunol 155:3610-3618, 1995
37. GRANDALIANO G, GESUALDO L, RANIERI E, MONNO R, MONTINARO V, MARRA F, SCIIENA FP: Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: A pathogenetic role in interstitial monocytes recruitment. J Am SocNephrol 7:906-913, 1996
38. PRODJOSUDJADI W, GERRITSMA JS, VAN Es LA, DAIIA MR, BRUIJN JA: Monocyte chemoattractant protein-1 in normal and diseased human kidneys: An immunohistochemical analysis. Clin Nephrol 44:148-155, 1995
39. LEWIS MP, NORMAN JT: Differential response of activated versus non-activated renal fibroblasts to tubular epithelial cells: A model of initiation and progression of fibrosis? Exp Ncphrol 6:132-143 1998
40. JOHNSON DW, SAUNDERS HJ, BAXTER RC, FIELD MJ, POLLOCK CA: Paracrine stimulation of human renal fibroblasts by proximal tubule cells. Kidney lut 54:747-757, 1998
41. MIZUNO S, KUROSAWA T, MATSUMOTO K, MIZUNO-HORIKAWA Y, OKAMOTO M, NAKAMURA T: Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 101:1827-1834, 1998
42. TAKAYAMA H, LAROCHELLE WJ, SABNIS SG, OTSUKA T, MERLINO G: Renal tubular hyperplasia, polycyslic disease, and glomerulosclerosis in transgcnic mice overexpressing hepatocyte growth factor/scatter factor. Lab Invest 77:131-138, 1997